Entry note
CRSP: Mean reversion desk
Looks for fast moves that stretched too far and may snap back. CRISPR Therapeutics is back near $186.50, so the desk marked it as actionable. If price loses $178.11, the idea gets downgraded quickly.
$186.50Entry
$178.11Risk rule
$200.49Focus